Alaa Aldeen
Lead AI Engineer & Generative Biology Architect
Multi-award-winning Life Sciences Innovator, AI Engineer, and Biotechnology Founder with a cross-disciplinary background spanning Medicine & Surgery Medical Studies (University of Al Fasher), Medical Sciences (BSc Hons, Swansea University), Deep Neural Networks, and Medical Device Invention. Architect of Zenith v31.0 GOLD, a 5,009-dimensional latent space single-cell foundation model trained on 2.42 million human cardiac cells, and lead designer of NL-101 (reversing biological heart cell age by -13.0 years with zero arrhythmia risk).
Silver Medalist at the 50th International Exhibition of Inventions Geneva for inventing the Real-Time Antigen-Antibody Detection (RTAAD) diagnostic device. Granted patent holder, UK IPO design rights holder, and winner of multiple international research medals. Certified in Good Clinical Practice (GCP/NIHR), combining clinical precision with advanced AI engineering.
Generative AI & Single-Cell Architecture
- • Deep Neural Network Model Training: Trained Zenith v31.1 GOLD, a 5,009D latent space single-cell variational autoencoder (scVI/PyTorch) featuring native BiT Age RNA clock modeling across 2.42 million human cardiac single-cell transcriptomes.
- • Large Language Models & Bio-Transformers: Integrated bio-LLM and transformer architectures for zero-shot gene perturbation prediction, mRNA sequence generation, and algorithmic codon optimization.
- • Multi-Agent AI Systems & Workflow Engines: Architected Promatly.com, an enterprise multi-agent task orchestration platform running parallel LLM API jobs, webhooks, and RESTful microservices.
- • Biophysical Safety Controls: Electrophysiological Stability Index (ESI: 0.96 ± 0.02) enforcing >94% Connexin-43/GJA1 & Troponin T retention with zero simulated rotor formation, bounded under Conformal Risk Control (CRC, 99% coverage).
- • Robotics Automation: Automated CSV/Python protocol engines for Opentrons OT-2 liquid handling robots.